Random People Armed with AI and No Lawyer Are Reportedly Filling Judicial Dockets with Lawsuits

Thanks to AI, plaintiffs representing themselves, also known as “pro se” plaintiffs, are changing the legal landscape for the ...
ZDNet

The best free AI courses and certificates for upskilling in 2026 - and I've tried them all

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...
NBC Chicago

What would you name your racehorse? Try our name generator

A lot of thought goes into naming a racehorse. Some people take inspiration from the horse’s pedigree, while others make it more personal, naming the horse after something special to the owner: a ...
The Hindu

Your name in Landsat: How to use NASA’s satellite name generator

The tool can find one’s name (or any other text) among the vast geological structures of Earth. For example, the letters that make up ‘The Hindu’ can resemble a firn-filled Fjord in Tibet or Lake ...
The Courier-Journal

What's your Kentucky Derby horse name? Use our generator to find out

One of the best parts of the Kentucky Derby is listening to Travis Stone, the Churchill Downs Racetrack announcer, rapidly list off the name of each Kentucky Derby horse. So, what is your Kentucky ...
Reuters

Generate Biomedicines shares fall in weak Nasdaq debut for drug developer

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...
FierceBiotech

Behind Generate's 'feverish' race to raise $400M IPO while window remains open

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...
Reuters

Flagship-backed Generate Biomedicines eyes $2.2 billion valuation in US IPO

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...
Scientific American

This mathematician proved a brilliant theorem to justify his social awkwardness

More than 100 years ago Hungarian-born mathematician George Pólya found himself trapped in a loop of social awkwardness. A professor at the Swiss Federal Institute of Technology Zurich, he enjoyed ...
Seeking Alpha

Generate Biomedicines Begins IPO Push With Major Collaboration Deals

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...
FierceBiotech

Flagship-founded antibody biotech Generate is latest to mull IPO

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...